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GENETIC DISORDERS – DEVELOPMENT
Flaxseed ameliorates interstitial nephritis
in rat polycystic kidney disease
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Flaxseed ameliorates interstitial nephritis in rat polycystic comfort. Charlemagne regulated its distribution and use
kidney disease. to maximize health benefits to his subjects [1]. These
Background. Flaxseed has demonstrated useful antiinflam- early anecdotal reports have been supported by morematory properties in a number of animal models and human
recent scientific evidence that ascribes benefit to flaxseeddiseases. We undertook a study to determine if flaxseed would
and flaxseed products in modification of cancer risk [2,also modify clinical course and renal pathology in the Han:
SPRD-cy rat. 3], serum cholesterol [4], and inflammatory and fibrotic
Methods. Male Han:SPRD-cy rats were pair fed a 10% flax- disorders such as lupus erythematosus nephritis [5, 6] or
seed or control rat chow diet for eight weeks from weaning. the 5/6 nephrectomy model of chronic renal failure [7].Tissue was harvested for analysis of cystic change, apoptosis,
The Han:SPRD-cy rat is a model of polycystic kidneycell proliferation, and fibrosis. Tissue was also harvested for
disease (PKD) that shares autosomal dominant inheri-lipid analysis using gas chromatography.
Results. Animals thrived on both diets. Flaxseed-fed animals tance, progression through early adult life, and sexual
had lower serum creatinine (69 vs. 81 mmol/liter, P 5 0.02), dimorphism with human disease [8]. The disease is char-
less cystic change (1.78 vs. 2.03 ml/kg, P 5 0.02), less renal acterized by progressive dilation of nephrons in youngfibrosis (0.60 vs. 0.93 ml/kg, P 5 0.0009), and less macrophage
animals, associated with marked interstitial inflamma-infiltration (13.8 vs. 16.7 cells/high-power video field) of the
tion and fibrosis with associated nephron loss in olderrenal interstitium than controls. The groups did not differ in
renal tubular epithelial cell apoptosis and proliferation. Lipid animals [9]. Unlike human PKD, Han:SPRD-cy rat PKD
analysis revealed significant renal enrichment of 18 and 20 has proved amenable to treatment. Modification of this
carbon v3 polyunsaturated fatty acids (total v6:v3 ratio 3.6 model of PKD has been achieved with a variety of envi-vs. 9.1, P , 0.0001).
ronmental manipulations, including dietary protein re-Conclusions. Flaxseed ameliorates Han:SPRD-cy rat poly-
striction [10], angiotensin-converting enzyme inhibitioncystic kidney disease through moderation of the associated
chronic interstitial nephritis. The diet alters renal content of [11] or angiotensin receptor blockade [12], salt loading
polyunsaturated fatty acids in a manner that may promote the [12], methyl-prednisolone therapy [13], or hypocholest-
formation of less inflammatory classes of renal prostanoids. erolemic therapy [14].
We have recently shown that substitution of soy pro-
tein for casein into the diet of Han:SPRD-cy rats results
Renewed interest in flaxseed, the seed of Linum usitat- in slower disease progression and dramatic reduction in
issimum, as an important source of human nutrition has interstitial inflammation and fibrosis [15]. As flaxseed
arisen both out of a shift to “natural foods” in the diets has shown beneficial results in other forms of renal injury
of developed countries and out of growing evidence of and has been claimed to produce benefits to general
direct effects on health or progress of disease. Flax has health comparable to soy [1, 5–7], we undertook a study
been cultivated as a diet staple and a source of plant to test the hypothesis that dietary flaxseed supplementa-
fiber for over 3,000 years and was ascribed medicinal tion would modify the clinical course and renal pathology
benefits by Hippocrates for the relief of intestinal dis- of male Han:SPRD-cy rats.
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Table 1. Diet composition croscope light source (see later here). Animals were clas-
sified as affected if a single longitudinal cross-section ofControl Flax
the kidney contained at least 10 areas of tubular dilationProtein % by weight 22.5 22.5
Digestible carbohydrate 55 55 with associated increase in extracellular matrix. High-
% by weight powered microscopic examination is used in cases of
Lipids 5 5
mild disease expression in our laboratory to insure thatFatty acids analysis % total lipidsa
14:0 1.5 0.8 lymphatic or empty vascular spaces are not being erron-
16:0 17.5 12.5 eously counted, but this was not necessary in this trial
16:1 1.8 1.1
in either feeding group. Classification was confirmed by17:0 6.1 4.7
18:0 7.2 5.6 two experienced observers (N.B.C. and M.R.O.).
18:1 25.0 22.6 Cell proliferation was studied using immunohisto-
18:2 x6 33.3 25.9
chemical detection of proliferating cell nuclear antigen18:3 x3 4.0 23.8
(PCNA) as previously reported [15]. Antigen detectiona Excluding fatty acids present at ,1% of total
was enhanced by microwave preheating in citric acid
buffer [17]. Sections were incubated with a monoclonal
anti-PCNA antibody (Dako M 0879; Dako A/S, Glost-
rup, Denmark) at a dilution of 1:50 for 90 minutes. Sec-Kansas Medical Center, Kansas City, KS, USA). All
animal procedures and care were examined by the Uni- ondary detection was achieved with a Vectastain Elite
rat adsorbed antimouse IgG kit (Vector Laboratories,versity of Manitoba Committee on Animal Use and were
certified to be within the guidelines of the Canadian Burlingame, CA, USA) with peroxidase-diaminobenzi-
dine color development.Council on Animal Care. Surviving male offspring of
known Han:SPRD-cy heterozygotes were used in this Macrophages were identified using a monoclonal anti-
body against a 90 to 100 kDa protein that is expressedstudy. Two thirds of these animals would be expected
to be heterozygous, as homozygotes in our colony rarely on lysosomal membranes and has many characteristics
of the human CD68 antigen (Chemicon MAB1435;survive beyond weaning.
Male animals were randomly assigned to treatment or Chemicon International Inc., Temecula, CA, USA) at a
dilution of 1:100 for 90 minutes [15]. Secondary detectioncontrol groups at weaning. Control animals received a
standard powdered rat chow (Agway Prolab R-M-H was achieved in the same way as for PCNA.
Apoptotic nuclei were identified using a cell death3500, Waverly, NY, USA) all taken from a single manu-
facturer’s batch. Experimental animals received a diet detection kit (Boehringer Mannheim 1 684 817; Boeh-
ringer Mannheim, Mannheim, Germany) with nickel-consisting of 80% rat chow from the same batch as the
control animals to which was added 10% by weight corn peroxidase color development using the manufacturer’s
procedures [15].starch and 10% by weight ground whole flaxseed (a kind
gift of Johnson Feeds, Morden, Manitoba, Canada). The
Image analysiscomposition of this diet is summarized in Table 1. Ani-
mals on experimental diet were pair fed with animals on Image analysis procedures were performed with a sys-
tem consisting of a Cohu high-resolution black and whitecontrol diet. Animals were killed after eight weeks on
the diet, and kidney tissue and serum were collected for camera connected to a computer via a PCVisionPlus
video capture board. Images were captured using theanalysis.
Image Pro software package (Phoenix Biotechnology,
Histology Seattle, WA, USA) [10, 15].
Renal volume was determined using the CavalieriTissue from the left kidney was used for histologic
and immunohistochemical analysis. This tissue was fixed principle as we have described previously. Parallel 2.5
mm sections of the left kidney were cut using a Lucitein 10% formalin for 120 minutes prior to embedding in
paraffin and sectioning at 5 microns. Sections for mea- guide box constructed for this purpose. A video image
of all sections, including a linear scale, was captured, andsurement of cystic volume and qualitative study of renal
histology were stained with hematoxylin and eosin. Sec- the area of the sections was integrated using module
2500 of the Imagemeasure software package (Phoenixtions for quantitative analysis of fibrosis were stained
using aniline blue alone in adaptation of Masson’s tri- Biotechnology) and renal volume calculated as the prod-
uct of total section area and section thickness.chrome stain [16]. This adaptation demonstrates a per-
fect concordance of staining with an immunofluorescent Measurement of relative tubular luminal area, that is,
the fraction of tissue section occupied by tubular lumen,detection of collagen type III (Fig. 1) using a rabbit
antirat collagen III antibody (AB757; Chemicon, Teme- was performed fluorometrically using the IM4100 mod-
ule of the Imagemeasure software package (Phoenix Bio-cula, CA, USA). The aniline blue staining permits image
analysis measurement using a standard incandescent mi- technology) using low-power microscopic images cap-
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Fig. 1. (A) Immunofluorescent detection of collagen type III in a section from a Han:SPRD-cy kidney 3100 magnification. (B) Sequential section
to that in (A) stained with aniline blue and photographed under red light, magnification 1003, duplicating image analysis conditions. The positive
area corresponds to the area that binds an anticollagen type III antibody.
tured via a Cohu high-resolution black and white video The product of the proportion and the reference renal
volume, corrected to body weight, gives the final volumecamera. Sections were viewed through a 23 objective
and Nikon TV relay lens. The samples were illuminated occupied by either renal cyst volume or renal fibrous
tissue [18].with a wide aperture condenser to insure uniform light-
ing conditions. The profiling tool within the program was Macrophage numbers, PCNA-positive cells, and apop-
totic cells were quantitated by counting, using moduleused to insure uniform lighting of the captured video
image. A 64 3 64 pixel rectangle was moved in an alter- 2500 of the Imagemeasure software package. The macro-
phage counts were reported as a mean per high-powernating horizontal and vertical path through the section
from a random starting point until 50 measurements video field (hpf; 403 microscope objective) with at least
50 fields counted. Apoptotic cells and PCNA-positivefrom each of four separate whole kidney tissue cross-
sections had been collected. The inner fluorometric cells were reported per millimeter of epithelium. The
length of the apical surface of a randomly selected piecethreshold was adjusted for each slide to include all gray
scale values equal to or greater than open tubular lumen. of epithelium was measured from a captured video image
using the same software module. Cells along the length ofSome cysts contained eosinophilic debris, but this mate-
rial had gray scale values of less than that of solid renal this piece that exhibited the appropriate nuclear staining
characteristics were then counted. The score for the kid-tissues and did not influence results. The outer threshold
was set to one (black) to include all stained areas of ney was determined as the mean count divided by the
mean length from 50 measurements.tissue and the relative tubular luminal area calculated
according to the following formula:
Chemistry
A 5 Xi/Xo
Serum creatinine and cholesterol were determined in
where A 5 relative area ratio, Xi 5 number of pixels serum by spectrophotometric methods using Sigma kits
within inner threshold, and Xo 5 number of pixels within (Sigma Chemical Co., St. Louis, MO, USA).
outer threshold.
Gas chromatographyAn average of 50 measurements from three to five
different sections was used to determine the cyst area Lipids were extracted for gas chromatographic analy-
sis using a modified Folch extraction procedure [19].ratio. A measurement was accepted if the 95% confi-
dence intervals of the mean were within 2% of the mean. Tissue from the right kidney that had been snap frozen
in liquid nitrogen and stored at 2708C was homogenizedRenal fibrous volume was measured in a similar way,
using the proportion of section areas that had taken up in 2:1 chloroform:methanol containing 0.05 mg/ml of bu-
tylated hydroxy toluene. After centrifugation at 3,500 ganiline blue stain as measured in densitometry mode of
module 4100 of the Imagemeasure software package. In for 15 minutes at 48C, the supernatant was treated with
an equal volume of 0.73% NaCl and was recentrifuged.the densitometry mode, the thresholds are reversed, with
the outer threshold set to 255 (white) and the inner The aqueous phase was discarded, and the organic phase
was washed twice with equal volumes of the theoreticalthreshold set one gray scale unit over the actual mea-
sured value of an area of interstitial aniline blue staining. upper phase (3:48:47 chloroform:methanol:water), with
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Table 2. Morphometric analysis of polycystic kidney disease (PKD) in Han:SPRD-cy rats receiving flaxseed supplemented or control diets
Control Flax P
N 22 19
Total renal volume ml/kg body wt 8.54 (1.33) 8.22 (1.09) NS
Relative cyst area 0.237 (0.027) 0.218 (0.035)
Cyst volume ml/kg body wt 2.03 (0.50) 1.78 (0.29) 0.02
Apoptosis positive cells/mm epithelium 22.8 (3.2) 21.9 (4.1) NS
PCNA positive cells/mm epithelium 29.1 (3.5) 29.9 (3.0) NS
Aniline blue staining ratio 0.109 (0.034) 0.072 (0.011) 0.0003
Renal fibrous volume ml/kg body wt 0.93 (0.38) 0.60 (0.13) 0.0009
Macrophage infiltration 16.7 (4.2) 13.8 (3.8) 0.026
cells/high power video fielda
Numbers are group means with standard deviations in parentheses. NS is not significant.
a Due to technical problems with tissue, N 5 21 for control and 18 for flaxseed for macrophage immunohistochemistry
each wash followed by a 30-minute centrifugation at not differ between the two treatment groups (Table 2).
Renal fibrous volume, however, was reduced in flaxseed-3,500 g at 48C, after which the theoretical upper phase
supplemented animals (0.60 ml/kg vs. 0.93 ml/kg, P 5and interphase layers were removed by siphoning. The
0.0009; Table 2). A parallel decrease was seen in theremaining organic layer was dried under nitrogen at
number of macrophages infiltrating the kidney (13.8308C, resuspended in 100 ml of 2:1 chloroform:methanol,
cells/hpf vs. 16.7 cells/hpf, P 5 0.026; Table 2). Normaland stored in a glass microvial under nitrogen gas. Crude
animals on either diet expressed cells that were positivelipid extracts were transmethylated using methanolic
for PCNA, apoptosis, and macrophage markers in veryHCl (3 n) at 1008C for 15 minutes. Fatty acid methyl
occasional microscopic fields, giving counts too low foresters were separated by gas liquid chromatography on
meaningful analysis between dietary groups.a Varian Star 3400 instrument, using a DB 225 30 meter
Serum creatinine was significantly lower in flaxseed-column (J&W Scientific Inc., Folsom, CA, USA). Chro-
fed Han:SPRD-cy animals (69 mmol/liter vs. 81 mmol/matographs were integrated using Varian GC Star soft-
liter, P 5 0.02; Table 3). Serum creatinine in normalware, version 3.0. Fatty acid methyl esters were identified
animals was not influenced by diet (flaxseed 67 6 14by comparison to retention times of Supelco37 compo-
mmol/liter vs. control 69 6 19 mmol/liter). The diet didnent FAME mix and were expressed as percentage total
not, however, have any hypocholesterolemic effect onlipid.
Han:SPRD-cy animals (Table 3). Analysis for fatty acid
content from affected kidneys revealed that flaxseed sup-Statistical analysis
plementation was associated with a small reduction inData were analyzed using Student’s t-test with the
renal palmitate content, a significant reduction in arachi-Welch correction for unequal variances using the Prism2
donic acid, and significant increases in C18:3 and C20:5software package (Graphpad Software, San Diego, CA,
v3 unsaturated precursors to prostanoid synthesis. TheUSA).
ratio of v6:v3 unsaturated fatty acids was significantly
decreased in renal tissue from animals fed the flaxseed
diet (0.30 vs. 0.11, P , 0.0001). The v3 polyunsaturatedRESULTS
fatty acid (PUFA) inhibitor of macrophage activity, do-Affected Han:SPRD-cy animals fed both flaxseed-sup-
cosahexaenoic acid (DHA), was reduced in animals fedplemented (N 5 19) and control diets (N 5 22) thrived
a flaxseed diet (Table 4). Representative chromato-with mean weights at sacrifice of 381 6 17 g and 369 6
graphs are shown in Figure 3.18 g, respectively (P 5 NS). All animals survived to the
conclusion of the feeding trial.
Flaxseed had no significant effect on total renal vol- DISCUSSION
ume in Han:SPRD-cy rats (8.22 ml/kg vs. 8.54 ml/kg; It has been proposed that PKD represents disrupted
Table 2). Littermates (N 5 8 flaxseed diet, N 5 4 on regulation of normal renal repair mechanisms, in re-
control diet) with normal kidneys also did not show any sponse to an ongoing injury or injuries that provoke a
difference in renal volume in response to diet (4.68 ml/ particularly prominent epithelial proliferative response
kg vs. 4.58 ml/kg). [20]. As the pathology of PKD is the sum of nonspecific
Histologic studies revealed that flaxseed feeding was changes, therapeutic benefit may be achieved by inter-
associated with a modest reduction in cystic change (1.78 ventions that do not remedy the expression of a mutant
ml/kg vs. 2.03 ml/kg, P 5 0.02; Fig. 2 and Table 2). gene [21]. The benefit of flaxseed products has been
Markers of tubular remodeling, including frequency of previously demonstrated in human and murine systemic
lupus erythematosus [5, 6], experimental models of mam-both apoptotic nuclei and nuclei expressing PCNA, did
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Fig. 2. (A) Renal tissue from a Han:SPRD-cy rat fed standard rat chow stained with hematoxylin and eosin, 340 magnification, cyst volume 5
2.03 ml/kg. (B). Renal tissue from a Han:SPRD-cy rat fed 10% flaxseed supplemented rat chow stained with hematoxylin and eosin, 403
magnification, cyst volume 5 1.65 ml/kg.
Table 4. Kidney lipid analysis in Han:SPRD-cy rats receivingTable 3. Biochemistry in Han:SPRD-cy rats receiving flaxseed
supplemented or control diets flaxseed supplemented or control diets
Control FlaxseedControl Flaxseed
(N 5 22) (N 5 19) P Lipid % total lipid weight:weight (N 5 22) (N 5 19) P
16:0 20.9 (1.8) 18.2 (1.3) ,0.0001Serum creatinine lmol /liter 81 (14) 69 (20) 0.021
Serum cholesterol mmol /liter 2.0 (0.3) 2.0 (0.3) NS 16:1 2.2 (1.3) 1.0 (0.5) 0.003
17:0 4.3 (1.9) 4.2 (1.6) NSData are group means with standard deviation in parentheses.
18:0 11.5 (2.9) 12.3 (2.7) NS
18:1 n7 2.4 (0.1) 2.1 (0.1) ,0.0001
18:1 n9 16.4 (5.6) 14.8 (4.5) NS
18:2 (v6) linoleic acid 19.5 (4.0) 19.6 (3.1) NS
18:3 (v3) a-linolenic acid 1.1 (0.5) 6.4 (3.2) ,0.0001mary [3] and colonic cancer [2], hypercholesterolemia
20:0 0.3 (0.1) 0.3 (0.1) NS
[4], and glomerulosclerosis induced by renal ablation 20:1 0.2 (0.1) 0.3 (0.1) NS
20:2 (v6) 0.5 (0.1) 0.4 (0.1) NS[7]. Our results demonstrate that the potential beneficial
20:3 (v6) 0.5 (0.2) 0.4 (0.2) NSinfluence of flaxseed dietary substitution on inflamma-
20:3 (v3) 0.01 (0.02) 0.2 (0.1) ,0.0001
tory disease extends to the renal tubulointerstitium in 20:4 (v6) arachidonic acid 14.3 (5.9) 10.1 (6.8) 0.03
20:5 (v3) eicosapentaenoic acid 0.4 (0.1) 1.0 (0.5) ,0.0001addition to the previously observed benefits in glomeru-
22:0 0.5 (0.1) 0.5 (0.2) NSlar pathology. It is possible that the reduction in cystic
22:1 0.3 (0.4) 0.4 (0.3) NS
change observed is a secondary effect of modification 22:5 (v3) docosopentaenoic acid 0.6 (0.2) 0.9 (0.4) 0.002
22:6 (v3) docosohexaenoic acid 1.7 (0.5) 1.3 (0.7) 0.02of the extracellular matrix, which is known to have a
23:0 0.9 (0.4) 0.6 (0.3) 0.0008powerful influence on the behavior of epithelium [22].
24:0 1.2 (0.6) 1.1 (0.6) NS
The lack of difference in cell proliferation or apoptosis 24:1 0.4 (0.2) 0.4 (0.2) NS
v6:v3 ratio 9.1 (0.5) 3.6 (1.1) ,0.0001scores suggests that reduced cyst volume occurs either
as a result of change in secretory or absorptive behavior Data are group means with standard deviation in parentheses.
or because of a shift in remodeling indices that is beneath
the sensitivity of these measures.
Flaxseed is a rich source of v3 unsaturated fatty acids,
tion to the 20 carbon species [26], which then competevitamin E, and the diphenolic ester secoisolariciresinol
for entry into the lipooxygenase and cyclooxygenasediglycoside that is metabolized by intestinal bacteria to
pathways [27]. Direct inhibition of v6 PUFA metabolismthe phytoestrogens enterodiol and enterolactone [1, 23].
in these pathways by v3 PUFA has also been proposedThe observed benefits of flaxseed products in inflamma-
[28]. This competition ultimately shifts the balance intory or fibrotic conditions is similar to that previously
production of prostaglandins and leukotrienes betweendescribed with fish oils that are also rich sources of v3
group 2 prostanoids produced when v6 PUFA enter theunsaturated fatty acids [24, 25]. v3 (a-linolenic, eicoso-
pathway and group 3 prostanoids when the substrate ispentanenoic) and v6 (linoleic, homo-g-linolenic, arachi-
v3 PUFA [29]. Gibson et al suggest that the reduceddonic) PUFAs are precursors for prostanoid synthesis.
inflammatory activity seen in association with v3 PUFA-The 18 carbon species compete at the level of the rate-
limiting enzyme, D6 reductase, which precedes elonga- enriched diets arises from the substantially lower potency
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Fig. 3. Representative gas chromatographs.
Gas chromatographs from (A) an animal on
control diet and (B) an animal on flax diet.
Peak assignments are as follows: 1, C16:0; 2,
C16:1; 3, C17:0 (standard); 4, C18:0; 5, C18:1;
6, C18:2; 7, C18:3; 8, C20:4; 9, C20:5; 10, C22:5;
11, C22:6.
of group 3 prostanoids as promoters of inflammation (MCP-1) pathway [36]. We have previously shown that
down-regulation of renal interstitial inflammation and[27]. These pathways are thought to be responsible for
the antithrombogenic effects of v3 PUFA [30]. v3 fibrosis by dietary protein restriction, a potentially femi-
nizing state, is associated with decreased expression ofPUFAs are precursors to docosahexaenoic acid, a potent
inhibitor of a number of macrophage functions that have MCP-1 [37]. Lignans are strongly suspected as the active
ingredients in the tumor-suppressive activity of flax [2, 3].been implicated as active ingredients in anti-inflamma-
tory fish oil diets [25, 31]. Our study, however, failed to Flaxseed represents a practical dietary intervention
with demonstrable effects on lipid metabolism, immunedemonstrate renal enrichment of this compound, sug-
gesting that if v3 PUFAs are responsible for the ob- function, and endocrine function at modest and palatable
intakes in humans [4, 38, 39]. Substitution of flaxseed orserved histologic effects, a prostanoid-mediated mecha-
nism would be more likely. Our study and that of Ingram a flax meal up to 15% of the flour content of baked goods
is associated with excellent culinary results [1], makinget al confirm that flaxseed supplementation may substan-
tially alter the PUFA content of the kidney [7]. In the intakes in the ranges quoted earlier in this article possible
within the context of normal dietary items without thelatter study, however, both flaxseed and oil had a lesser
effect on a-linolenic acid, whereas flax oil had a greater need for special supplements.
Recent efforts to demonstrate a benefit of dietary ther-effect on eicosapentaenoic acid than in our study. Flax-
seed treatment in that study was also associated with an apy in renal disease in the form of protein-restrictive
diets have produced disappointing results [40]. The grow-increase in arachidonic acid. The diet in that study used
a high total protein content, with the majority of the ing evidence for a renal anti-inflammatory role for oil
seed products such as soy or flax raises the possibility thatprotein as casein. The type of protein ingested influences
activity of hepatic enzymes associated with PUFA syn- more positive dietary strategies may yet be developed to
ameliorate chronic renal injury.thesis, particularly D6 desaturase [32], and this may ac-
count for the differences with our results where the pro-
tein source was of lower biologic value from a mixture ACKNOWLEDGMENTS
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